Mira Pharmaceuticals (MIRA) Retained Earnings (2022 - 2025)

Mira Pharmaceuticals has disclosed Retained Earnings across 4 years of filings, most recently posting -$39.6 million for Q4 2025.

• Retained Earnings for Q4 2025 came in at -$39.6 million, down 35.84% year-over-year; the trailing twelve-month figure through Dec 2025 was -$39.6 million (down 35.84% YoY), and the FY2025 annual result was -$39.6 million, down 35.84% from the prior year.
• Retained Earnings came in at -$39.6 million for Q4 2025 at Mira Pharmaceuticals, down from -$33.6 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$9.3 million in Q4 2022 to a low of -$39.6 million in Q4 2025.
• The 4-year median for Retained Earnings is -$26.7 million (2024), against an average of -$24.9 million.
• Across the five-year window, Retained Earnings sank 128.8% in 2023 and retreated 25.65% in 2025, its largest moves.
• Mira Pharmaceuticals' Retained Earnings stood at -$9.3 million in 2022, then tumbled by 128.8% to -$21.3 million in 2023, then sank by 36.89% to -$29.1 million in 2024, then slumped by 35.84% to -$39.6 million in 2025.
• The last three Retained Earnings figures came in at -$39.6 million (Q4 2025), -$33.6 million (Q3 2025), and -$32.5 million (Q2 2025), per Business Quant data.